Economic Model Projects Potential EU Healthcare Savings from Omega-3 Intake

A recent economic modelling study indicates that widespread omega-3 supplementation could lead to substantial annual savings in European Union healthcare expenditure. The research projects potential savings, primarily by reducing the incidence of cardiovascular disease (CVD) events. ### Projected Healthcare Cost Reductions The study modelled the economic impact of achieving recommended omega-3 intake levels across the EU population. The primary focus was on the prevention of CVD events, including myocardial infarction and stroke, among adults aged 55 and older. The model considered a scenario where 80% of the EU population aged 55 and above consumed 1 gram of EPA+DHA daily. This dose and population segment were selected to reflect a targeted public health intervention aimed at reducing a significant burden of disease. ### Return on Investment The research suggests a potential return on investment for preventative strategies involving omega-3s, highlighting the potential economic efficiency of such interventions. ### Implications for the Supplement Industry These findings provide further evidence regarding the potential public health benefits of omega-3 fatty acids (EPA and DHA) and could support initiatives to encourage broader adoption of supplementation. For manufacturers, formulators, and brand owners, the study points to a growing recognition of omega-3s as a component of preventative healthcare strategies, potentially influencing future market demand and regulatory discussions within the EU.